A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving Rituximab

Primary biliary cirrhosis (PBC) is a progressive liver disease for which limited therapies are recommended. Rituximab, an anti-CD20 monoclonal antibody, is expected to be a useful therapeutic regimen for PBC. Previous studies indicated biochemical and immunological improvement in PBC after rituximab...

Full description

Bibliographic Details
Main Authors: Tajiri, Kazuto, Tsuneyama, Koichi, Miyazono, Takahiro, Kawai, Kengo, Minemura, Masami, Sugiyama, Toshiro
Format: Online
Language:English
Published: S. Karger AG 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656669/